4月13日 -
** HeartflowHTFL.O股价盘前下跌2%至26.46美元
** 人工智能诊断公司称已在德克萨斯州联邦法院对竞争对手Cleerly提起专利侵权诉讼
** 该公司称，该案的目标是Cleerly公司用于发现心脏动脉阻塞的工具，这是心脏病发作的常见原因。
** 称Cleerly的 "缺血"、"斑块分析 "和 "比较 "产品侵犯了可追溯到2012年的六项专利
** 要求法院下令停止使用该技术，并要求赔偿损失 - HTFL
** 补充说，其人工智能平台可帮助医生利用心脏扫描评估冠状动脉疾病，而无需侵入性程序
** 截至上日收盘，股价年累计下跌约 15%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.